Acute rhabdomyolysis caused by combination therapy with atorvastatin and warfarin

被引：12
作者：
MacKay, J. W. [1 ]
Fenech, M. E. [1 ]
Myint, K. S. [1 ]
机构：
[1] Norfolk & Norwich Univ Hosp, Elsie Bertram Diabet Ctr, Norwich NR4 7UY, Norfolk, England
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2012年 / 73卷 / 02期
关键词：
D O I：
10.12968/hmed.2012.73.2.106
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：106 / 107
页数：2
相关论文
共 8 条
  • [1] Oral anticoagulant drug interactions with statins: Case report of fluvastatin and review of the literature
    Andrus, MR
    [J]. PHARMACOTHERAPY, 2004, 24 (02): : 285 - 290
  • [2] Iliadis E A, 1995, Pa Med, V98, P31
  • [3] The effect of converting from pravastatin to simvastatin on the pharmacodynamics of warfarin
    Lin, JC
    Ito, MK
    Stolley, SN
    Morreale, AP
    Marcus, DB
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (01) : 86 - 90
  • [4] Rhabdomyolysis and acute renal failure due to combination therapy with simvastatin and warfarin
    Mogyorósi, A
    Bradley, B
    Showalter, A
    Schubert, ML
    [J]. JOURNAL OF INTERNAL MEDICINE, 1999, 246 (06) : 599 - 602
  • [5] FDA adverse event reports on statin-associated rhabdomyolysis
    Omar, MA
    Wilson, JP
    [J]. ANNALS OF PHARMACOTHERAPY, 2002, 36 (02) : 288 - 295
  • [6] Atorvastatin does not alter the anticoagulant activity of warfarin
    Stern, R
    Abel, R
    Gibson, GL
    Besserer, J
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (11) : 1062 - 1064
  • [7] In vitro comparative inhibition profiles of major human drug metabolising cytochrome p450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors
    Transon, C
    Leemann, T
    Dayer, P
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 50 (03) : 209 - 215
  • [8] Potential interaction between warfarin and fluvastatin
    Trilli, LE
    Kelley, CL
    Aspinall, SL
    Kroner, BA
    [J]. ANNALS OF PHARMACOTHERAPY, 1996, 30 (12) : 1399 - 1402
1